Who We Are

Emmessar Biotech & Nutrition Ltd (EBNL) is a global healthcare company that manufactures and markets healthcare & nutritional products. Taking a holistic approach to managing healthcare concerns, EBNL fuses various concepts & principles (both ancient & modern) from Biophysics, Biochemistry, Biotechnology and the Indian system of medicine - AYUSH (Ayurveda + Yoga + Unani + Siddha + Homeopathy) to create a unique set of effective and curative products. The integration of all the aforementioned systems of medical sciences resulted in the birth of a new science & technology called VedaCeuticals which forms the foundation of all products of EBNL.

EBNL's range of products addresses various unmet medical needs of healthcare. We cater to patients with obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments. Presently, we have over 38 products across 7 categories that can treat over 200 different problems.

EBNL is a public limited company, with a paid-up Share Capital of about INR 50 million. The company's stocks are traded on the Bombay Stock Exchange Ltd (BSE).

Our Quality Management System is ISO 9001:2015 certified, our Occupational Health and Safety Management System is ISO 45001:2018 certified and our Environmental Management System is ISO 14001:2015 is certified.

Bg Bg

Our Vision

To propel an evolution towards a healthcare revolution by providing simple solutions to complex health problems.

Our Mission

To leverage the principles of VedaCeuticals through continuous innovation and create holistic healthcare solutions for -

  • All the Sick & Suffering - all genders and age groups
  • All the chronic patients who are clueless about the cause of their disease & sickness
  • All those who are frustrated with modern but long & ineffective treatments in hospitals & dispensaries
  • All those trusting consumers who are suffering from the adverse effects of toxic drugs

Our History

We are conscious of our eventful journey so far with inevitable ups and downs which we withstood. We look forward to more challenges that will lead us towards serving the humanity at large in the healthcare field.


July 07, 1984

Emmessar Metcast Pvt.Ltd., was established as a foundary to produce industrial metal castings. We progressively diversified into engineering & construction, involing different branches - Civil, Mechnical, Electrical, Instrumentation and Process Enginerring

July 1984 to March 1992

Our focus in R&D resulted in the design & development of special purpose machines and equipments, super specialty chemicals, biotech processes etc.


Mar 17, 1992

Having developed many products of considerable promise, particularly in the field of super specialty chemicals, a separate company Emmessar Chemical Industries Ltd (ECIL) was promoted and a multi-product manufacturing factory was built.

March 1992 to Sep 1994

Commenced development of D2EHPA (Octile Phosphoric Acid) for High Purity Metal Extraction in Hydrometallugry mainly for Atomic Energy Commission, India


Sep 29, 1994

Emmessar Metcast Pvt. Ltd. became Emmessar Engineering & Construction Pvt. Ltd. We commenced design and fabrication of special purpose machines for engineering & chemical industries including ECIL.

Sep 1994 to Jan 1996

Built another modern factory for manufacturing ‘Electronic Grade Sulphuric Acid’ that is used in the manufacture of multilayer PCBs and electronic chips for Electronics Industry


Dec 14, 1994

Public issue of Emmessar Chemical Industries Ltd” (ECIL). We got an overwhelming response. Our public issue got over-subscribed by 37 times.


Jan 15, 1996

ECIL’s R&D recognized by Department of Science & Industrial Research (DSIR) - Ministry of Science & Technology – New Delhi


Oct 14, 1997

Fire accident struck ECIL factories and reduced them to ashes. It took us the next 7 years to clear all the debts with financial institutions.

Oct 1997 to Oct 1998

Commenced development of many ECIL products in R&D - MSM, DMG, TMG, TEP, TMP etc.


Oct 5, 1998

Partnership started with Karl Loren, the founder of Vibrant Life. Karl was a world renowned oral chelation therapist for heart diseases. He was also the father of Anabiology and the founder of Institute of Anabiosis in USA. This science of Anabiology formed an integral part of the development of 'VedaCeuticals’. We started manufacturing healthcare products.

Oct 1998 to Apr 2000

We started appointing agents in different parts of the world to market the health care products.


Apr 7, 2000

Birth of Emmessar Biotech & Nutrition Ltd with a focus on Healthcare products

Jan 2001 to Jan 2002

Development of many healthcare products commenced based on a new science & technology named VedaCeuticals.


Jan 2001

CalmCream, a multi-purpose skin cream that treats many obstinate skin problems was launched

Jan 2002 to Jan 2003

Successful scientific clinical trials conducted for CalmCream in 3 well known government hospitals in Mumbai.


Jan 2003

MagiCream, a superior skin repair cream for cosmetic restoration of skin was launched

Jan 2003 to Jan 2004

EBNL products started to get recognition as reliable solutions from customers from various parts of the world


Feb 2004

Supportt Joint, an effective solution to treat osteoarthritis was launched


Mar 2005

Supportt Bones, an effective solution to treat osteoporosis was launched

Mar 2005 to Mar 2007

Patent for VedaCeuticals & other trade marks obtained.


Mar 8, 2007

Emmessar Engineering & Construction Pvt. Ltd became Emmessar Technologies Private Ltd (the original developer & owner of VedaCeuticals); Further intensified focus on R&D in the fields of Super Specialty Chemicals, Health Systems Engineering, Biotechnology and Product Development for Health Care through unique technologies


Aug 8, 2008

Emmessar Technologies Private Ltd became Emmessar Technologies Ltd (ETL)


Oct 2008

RESQ, an unfailing solution for treating all types of burns from heat & radiation was launched.


Nov 2008

Cute N Comely, a premier topical application with protective & therapeutic properties to ensure an optimal & natural skin rejuvenation process was launched.


Dec 2009

Frejomus tablets was launched to help mitigate joint pains that restrict movement for the middle and old aged people.


Sep 2010

Sepecer, a reliable solution for neurological and physiological health for the middle ages and beyond was launched.


Aug 2011

Psoribalm was launched to meet the long standing demand for a harmless & reliable treatment for the most obstinate & dangerous skin disease – Psoriasis.


Over 30 newly developed products to meet a spectrum of healthcare needs ready to be launched progressively from mid 2016 onwards.